IBM Secures $1 Billion Federal Award to Boost Quantum Wafer Manufacturing
International Business Machines (IBM) has received a significant federal award of $1 billion from the U.S. Department of Commerce under the CHIPS and Science Act. The funding is intended to accelerate quantum wafer manufacturing at Anderon, IBM's spin-off dedicated to quantum foundry operations. This non-dilutive financial support will be matched by an internal capital commitment of another $1 billion, enabling expansion of a 300-millimeter quantum wafer foundry in Albany, New York. The award is seen as validating IBM’s strategic shift toward high-margin deep-tech infrastructure and positions the company at the center of the quantum hardware supply chain. Analysts view this development favorably for IBM stock, potentially transforming its speculative research into a commercial advantage with government backing. Despite recent underperformance in 2026—IBM shares are down about 17% year-to-date—the firm remains attractive due to strong recurring revenue from software and AI platforms. Wall Street analysts maintain a 'Moderate Buy' rating for IBM, citing its transformation into an enterprise hybrid cloud and AI leader. The stock currently trades at a forward P/E of around 20x with a dividend yield of 2.82%, making it appealing to long-term investors.
Tickers: $IBM
Topics: CHIPS and Science Act federal funding IBM quantum computing